Affordable Inhalers and Nebulizers Act of 2025
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- House
- Sponsors
- 14
- Latest action
- Sep 10, 2025
What it does
The Affordable Inhalers and Nebulizers Act of 2025 would reduce patient cost sharing for prescription inhaler products used to treat asthma and chronic obstructive pulmonary disease by prohibiting deductibles and limiting cost-sharing to no more than $15 per 30-day supply under private health insurance, Medicare, and ERISA-covered plans, while also establishing a payment program for uninsured individuals to receive these products at no more than $15 per month’s supply. The bill applies to group health plans, health insurance issuers, Medicare Part B and Part D, and uninsured individuals, with provisions effective for plan years beginning on or after January 1, 2026. It defines specified…
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…
Where it goes next
While a bill can still move, the questions are about people and money.